ArticleInvestigational new drugs2008

Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia.

Markus Jensen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.